Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

241 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis.
Mao TL, Chu JS, Jeng YM, Lai PL, Hsu HC. Mao TL, et al. Among authors: lai pl. J Pathol. 2001 Jan;193(1):95-101. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH720>3.0.CO;2-3. J Pathol. 2001. PMID: 11169521
Mutations of p53 gene in hepatocellular-carcinoma (hcc) correlate with tumor progression and patient prognosis - a study of 138 patients with unifocal hcc.
Hsu H, Peng S, Lai P, Chu J, Lee P. Hsu H, et al. Among authors: lai p. Int J Oncol. 1994 Jun;4(6):1341-7. doi: 10.3892/ijo.4.6.1341. Int J Oncol. 1994. PMID: 21567059
Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC.
Lin ZZ, Jeng YM, Hu FC, Pan HW, Tsao HW, Lai PL, Lee PH, Cheng AL, Hsu HC. Lin ZZ, et al. Among authors: lai pl. BMC Cancer. 2010 Aug 28;10:461. doi: 10.1186/1471-2407-10-461. BMC Cancer. 2010. PMID: 20799978 Free PMC article.
Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma.
Yuan RH, Jeng YM, Hu RH, Lai PL, Lee PH, Cheng CC, Hsu HC. Yuan RH, et al. Among authors: lai pl. J Gastrointest Surg. 2011 Feb;15(2):321-9. doi: 10.1007/s11605-010-1373-x. J Gastrointest Surg. 2011. PMID: 21061181
Tumor size is a major determinant of prognosis of resected stage I hepatocellular carcinoma.
Huang WJ, Jeng YM, Lai HS, Sheu FY, Lai PL, Yuan RH. Huang WJ, et al. Among authors: lai hs, lai pl. Langenbecks Arch Surg. 2015 Aug;400(6):725-34. doi: 10.1007/s00423-015-1329-4. Epub 2015 Aug 7. Langenbecks Arch Surg. 2015. PMID: 26250145
Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.
Huang WJ, Jeng YM, Lai HS, Fong IU, Sheu FY, Lai PL, Yuan RH. Huang WJ, et al. Among authors: lai hs, lai pl. PLoS One. 2015 Mar 4;10(3):e0119181. doi: 10.1371/journal.pone.0119181. eCollection 2015. PLoS One. 2015. PMID: 25738958 Free PMC article.
Expression of bile duct transcription factor HNF1β predicts early tumor recurrence and is a stage-independent prognostic factor in hepatocellular carcinoma.
Yuan RH, Lai HS, Hsu HC, Lai PL, Jeng YM. Yuan RH, et al. Among authors: lai hs, lai pl. J Gastrointest Surg. 2014 Oct;18(10):1784-94. doi: 10.1007/s11605-014-2596-z. Epub 2014 Jul 23. J Gastrointest Surg. 2014. PMID: 25052070
TERT promoter mutation in resectable hepatocellular carcinomas: a strong association with hepatitis C infection and absence of hepatitis B infection.
Chen YL, Jeng YM, Chang CN, Lee HJ, Hsu HC, Lai PL, Yuan RH. Chen YL, et al. Among authors: lai pl. Int J Surg. 2014;12(7):659-65. doi: 10.1016/j.ijsu.2014.05.066. Epub 2014 May 24. Int J Surg. 2014. PMID: 24866078
S100P expression is a novel prognostic factor in hepatocellular carcinoma and predicts survival in patients with high tumor stage or early recurrent tumors.
Yuan RH, Chang KT, Chen YL, Hsu HC, Lee PH, Lai PL, Jeng YM. Yuan RH, et al. Among authors: lai pl. PLoS One. 2013 Jun 13;8(6):e65501. doi: 10.1371/journal.pone.0065501. Print 2013. PLoS One. 2013. PMID: 23785431 Free PMC article.
Expression of insulin-like growth factor II mRNA-binding protein 3 predicts early recurrence and poor prognosis in intrahepatic cholangiocarcinoma.
Chen YL, Jeng YM, Hsu HC, Lai HS, Lee PH, Lai PL, Yuan RH. Chen YL, et al. Among authors: lai hs, lai pl. Int J Surg. 2013;11(1):85-91. doi: 10.1016/j.ijsu.2012.11.021. Epub 2012 Dec 13. Int J Surg. 2013. PMID: 23246869
241 results
Jump to page
Feedback